Lexicon Pharmaceuticals Stock News

Premarket penny stocks to watch on December 31, 2021. The post Hot Penny Stocks To Buy Before 2022? 3 Premarket Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | Pen

Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade on the final trading day of 2021. The Dow Jones dropped around 90 points, snapping a six-session winning streak on Th

Premarket penny stocks to watch on December 31, 2021. The post Hot Penny Stocks To Buy Before 2022?

Some of the stocks that may grab investor focus today are: Medalist Diversified REIT, Inc. (NASDAQ: MDRR) reported a stock repurchase program of 500,000 shares. Medalist Diversified shares climbed 22

THE WOODLANDS, Texas, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administra

Parametric Portfolio Associates LLC lessened its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) by 7.4% in the 2nd quarter, Holdings Channel.com reports. The fund owned 85,846 shares of the biopharmaceutical companys stock after selling 6,855 shares during the quarter. Parametric Portfolio Associates LLCs holdings in Lexicon Pharmaceuticals were worth $394,000 at the end of the most [] The post Parametric Portfolio Associates LLC Cuts Stock Position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) appeared first on ETF Daily News .

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) shares, rose in value on Friday, 12/17/21, with the stock price up by 1.57% to the previous days close as strong demand from buyers drove the stock to $3.87. Actively observing the price movement in the last trading, the stock closed the session at $3.81, falling within a range of $3.72 Lexicon Pharmaceuticals Inc.s (NASDAQ: LXRX) Future In 2021 Read More »

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) price on Friday, December 10, fall -4.86% below its previous days close as a downside momentum from buyers pushed the stocks value to $4.11. A look at the stocks price movement, the close in the last trading session was $4.32, moving within a range at $4.085 and $4.39. The beta value Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) Is Expected To Rise To 20.00 USD! Read More »

Global Muscular Dystrophy Treatment Market has potentials to grow as the most influential market worldwide as it has been playing a noteworthy role in imprinting positive impacts on the international economy. The Global Muscular Dystrophy Treatment Market Report offers vital

Charles Schwab Investment Management Inc. lifted its holdings in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) by 11.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 469,704 shares of the biopharmaceutical company’s stock after purchasing an additional 46,478 shares during the […]

THE WOODLANDS, Texas, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its virtual participation in the following conferences:

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX ) has announced a new analysis evaluating the benefit of sotagliflozin in…

Post hoc analysis of pooled clinical data from the SOLOIST and SCORED trials supporting benefit of sotagliflozin presented at the virtual American Heart Association Scientific Sessions 2021, including

Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q3 2021 Results - Earnings Call Transcript

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM. Here's what investors need to know about the announcement.